Hefei Lifeon Pharmaceutical Co Ltd

SHE:003020 China Biotechnology
Market Cap
$630.64 Million
CN¥4.63 Billion CNY
Market Cap Rank
#13749 Global
#3556 in China
Share Price
CN¥24.33
Change (1 day)
+0.00%
52-Week Range
CN¥17.98 - CN¥38.76
All Time High
CN¥38.76
About

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethy… Read more

Hefei Lifeon Pharmaceutical Co Ltd (003020) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.343x

Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has a cash flow conversion efficiency ratio of 0.343x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥667.63 Million) by net assets (CN¥1.95 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hefei Lifeon Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Hefei Lifeon Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Hefei Lifeon Pharmaceutical Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.91 Billion CN¥197.53 Million 0.103x -5.00%
2023-12-31 CN¥1.87 Billion CN¥203.67 Million 0.109x -19.80%
2022-12-31 CN¥1.48 Billion CN¥200.64 Million 0.136x +11.37%
2021-12-31 CN¥1.30 Billion CN¥158.70 Million 0.122x -17.16%
2020-12-31 CN¥1.17 Billion CN¥172.49 Million 0.147x -41.94%
2019-12-31 CN¥590.00 Million CN¥149.30 Million 0.253x +98.55%
2018-12-31 CN¥505.70 Million CN¥64.45 Million 0.127x +307.11%
2017-12-31 CN¥361.71 Million CN¥11.32 Million 0.031x -84.18%
2016-12-31 CN¥298.09 Million CN¥58.99 Million 0.198x -53.66%
2014-12-31 CN¥215.53 Million CN¥92.05 Million 0.427x +112.57%
2013-12-31 CN¥176.88 Million CN¥35.54 Million 0.201x +458.44%
2012-12-31 CN¥141.96 Million CN¥-7.96 Million -0.056x --